+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative activity of cefotetan on Escherichia coli K12 possessing plasmid-mediated beta-lactamases



Comparative activity of cefotetan on Escherichia coli K12 possessing plasmid-mediated beta-lactamases



Journal of Antimicrobial ChemoTherapy 11 Suppl: 159-167



The antibacterial activity of cefotetan, a new cephamycin, was compared with that of cephalothin, cefoxitin, cefamandole, cefoperazone and cefotaxime on 12 substrains of Escherichia coli K12 BM13 harbouring single and multi-copy plasmids coding for plasmid-mediated beta-lactamases TEM, SHVI, OXA-I and OXA-III. The 99% inhibitory concentrations (IC99) for the recipient strain were increased in proportion to the enzyme activity in the case of cefamandole and cefoperazone. In contrast, the activity of cefoxitin, cefotaxime and cefotetan was not significantly modified. Since these enzymes are responsible for the resistance of Enterobacteriaceae in the great majority of clinical isolates, cefotetan can be expected to be fully active against strains producing them. Cefotetan was not hydrolysed by chromosomal cephalosporinase and it was active against Enterobacter, Citrobacter and Morganella strains producing a low level of enzyme but hyperproducing variants were highly resistant to cefotetan.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 042606240

Download citation: RISBibTeXText

PMID: 6341349


Related references

Comparative activity of cefotetan on Escherichia coli K12 possessing plasmid-mediated -lactamases. Journal of Antimicrobial ChemoTherapy 11(Suppl A): 159-167, 1983

Prevalence of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea. Microbial Drug Resistance 12(1): 44-49, 2006

Prevalence of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella spp. isolated in children. Zhonghua Yi Xue Za Zhi 90(38): 2723-2725, 2010

Enhanced laboratory detection of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella spp. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 42: 140, 2002

Plasmid-mediated quinolone resistance and beta-lactamases in Escherichia coli from healthy animals from Nigeria. 2011

Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli. Clinical Infectious Diseases 35(2): 140-145, 2002

Broad resistance due to plasmid-mediated AmpC beta-lactamases from Escherichia coli isolates in Chicago. Clinical Infectious Diseases 31(1): 212, 2000

A clinical strain of Escherichia coli possessing CMY-2 plasmid-mediated amp C beta-lactamase: an emerging concern in pediatrics?. Microbial Drug Resistance 8(4): 329-333, 2002

Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime. Antimicrobial Agents and ChemoTherapy 33(5): 757-761, 1989

PCR detection of plasmid mediated TEM, SHV and AmpC beta-lactamases in community and nosocomial urinary isolates of Escherichia coli. Iranian Journal of Biotechnology 3(1): 48-54, 2005

Investigation of plasmid mediated AmpC beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolated from blood cultures. Mikrobiyoloji Bulteni 47(4): 582-591, 2013

Rapid method for screening large numbers of Escherichia coli colonies for production of plasmid-mediated beta-lactamases. Antimicrobial Agents and ChemoTherapy 23(2): 308-312, 1983

Coexistence of plasmid-mediated quinolone resistance determinants and AmpC-Beta-Lactamases in Escherichia coli strains in Egypt. Cellular and Molecular Biology 61(5): 29-35, 2015

Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. Journal of Clinical Microbiology 43(8): 4163-4167, 2005

The prevalence of plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China. European Journal of Clinical Microbiology and Infectious Diseases 27(10): 915-921, 2008